Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
Go back to Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says| Johnson & Johnson (NYSE: JNJ) | Delayed: 254.66 +9.78 (3.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.88 | 52 Week High | $126.07 | |||
| Open | $248.27 | 52 Week Low | $94.28 | |||
| Day High | $255.11 | P/E | 52.94 | |||
| Day Low | $247.87 | EPS | $4.81 | |||
| Volume | 16,316,599 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 128.66 +3.21 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.45 | 52 Week High | $65.46 | |||
| Open | $125.83 | 52 Week Low | $47.97 | |||
| Day High | $128.78 | P/E | 87.52 | |||
| Day Low | $125.83 | EPS | $1.47 | |||
| Volume | 18,891,511 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 48.07 +0.43 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.64 | 52 Week High | $59.00 | |||
| Open | $47.12 | 52 Week Low | $32.80 | |||
| Day High | $48.50 | P/E | N/A | |||
| Day Low | $46.99 | EPS | $0.00 | |||
| Volume | 20,132,393 | |||||
